Global Benzodiazepine Drugs Market Outlook and Opportunity Analysis 2022-2030 with 2021 as base year – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The report “Global Benzodiazepine Drugs Market by Product, Application, Route of Administration, Distribution Channel, and Region – Size, Share, Outlook, and Opportunity Analysis, 2022-2030” has been added to from ResearchAndMarkets.com offer.
Benzodiazepines are still widely recognizable under brand names such as Valium or Xanax. They come in tablets and capsules and some are available for intravenous forms for use in a hospital setting.
Market players are engaged in expanding facilities, to expand their manufacturing plant and product portfolio. This is expected to drive the growth of the global benzodiazepine drugs market over the forecast period. For example, in January 2018, Torrent Pharmaceuticals Ltd. acquired Bio-Pharm, Inc., a U.S. generic and over-the-counter (OTC) pharmaceutical company that also included a U.S. Food and Drug Administration (FDA) registered 75,000 square foot manufacturing facility in the United States
Major players are engaged in getting their products approved by regulatory authorities. This is expected to drive the growth of the market over the forecast period. For example, in October 2018, Amneal Pharmaceuticals, Inc., an American biopharmaceutical company announced that a generic version of Onfi (clobazam) tablets, 10 mg and 20 mg for oral use, CIV, and Onfi (clobazam) oral suspension, 2.5 mg/mL, CIV, has been approved by the United States Food and Drugs Administration.
Main characteristics of the study:
-
This report provides an in-depth analysis of the global Benzodiazepine Drugs market, provides the market size (Million US$) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year.
-
It elucidates potential revenue opportunities across different segments and explains an attractive investment proposition matrix for this market.
-
This study also provides key insights into the market drivers, restraints, opportunities, new product launches or approvals, regional outlook, and competitive strategies adopted by key players.
-
It profiles leading players in the global Benzodiazepine Drugs market based on the following parameters: company overview, financial performance, product portfolio, geographic presence, distribution strategies, key developments and strategies, and future plans.
-
The information in this report would enable marketers and managing authorities of companies to make informed decisions regarding their future product launch, technology upgrade, market expansion and marketing tactics.
-
The Global Benzodiazepine Drugs Market report is targeted at various stakeholders of this industry including investors, suppliers, manufacturers, distributors, new entrants and financial analysts.
-
Stakeholders would have an ease in making decisions through various strategic matrices used to analyze the global Benzodiazepine Drugs market
Company Profiles
-
Hoffmann-La Roche Ltd.
-
Recent Highlights
-
Mallinckrodt Pharmaceuticals
-
Pfizer Inc.
-
Viatris Inc. (Mylan NV)
-
Labiana Pharmaceuticals
-
Bausch Health Companies, Inc.
-
Teva Pharmaceutical Industries Ltd.
-
Amneal Pharmaceuticals LLC
-
Sun Pharmaceutical Industries Ltd.
-
Aurobindo Pharmacy
-
By Pharmaceutical
-
Intas Pharmaceuticals Ltd
Main topics covered:
1. Research objectives and hypotheses
-
Research objectives
-
Hypotheses
-
Abbreviations
2. Market Overview
-
Description of the report
-
Market definition and scope
-
Summary
-
Market extract, by product
-
Market Extract, By Application
-
Extract from market, by administration
-
Market extract, by distribution channel
-
Market extract, by region
-
Opportunity map
3. Market dynamics, regulation and trend analysis
-
Market dynamics
-
Drivers
-
Constraints
-
Market opportunities
-
Impact analysis
-
Regulatory scenario
-
PEST analysis
-
Recent product launch/approval
-
Epidemiology
-
Mergers and Acquisitions
4. COVID – 19 Impact Analysis
-
Supply chain impact
-
Impact on research and development
-
Government initiatives
5. Global Benzodiazepine Drugs Market, by Product, 2017-2030 (USD Million)
-
Introduction
-
Market share analysis, 2022 and 2030 (%)
-
Annual Growth Analysis, 2018 – 2030
-
Industry trends
-
Long-acting benzodiazepines
-
Introduction
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Chlordiazepoxide
-
Diazepam
-
Lorazepam
-
Alprazolam
-
Clonazepam
-
Others
-
Short-acting benzodiazepines
-
Introduction
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Temazepam
-
Midazolam
-
Triazolam
-
Others
6. Global Benzodiazepine Drugs Market, By Administration Route, 2017-2030 (USD Million)
-
Introduction
-
Market share analysis, 2022 and 2030 (%)
-
Annual Growth Analysis, 2018 – 2030
-
Industry trends
-
Anxiety disorders
-
Introduction
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Nervousness
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Sedation
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Seizures
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Alcohol withdrawal
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
7. Global Benzodiazepine Drugs Market, By Route Of Administration, 2017-2030 (USD Million)
-
Introduction
-
Market share analysis, 2022 and 2030 (%)
-
Annual Growth Analysis, 2018 – 2030
-
Industry trends
-
Oral
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Injectables
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
8. Global Benzodiazepine Drugs Market, by Distribution Channel, 2017-2030 (USD Million)
-
Introduction
-
Market share analysis, 2022 and 2030 (%)
-
Annual Growth Analysis, 2018 – 2030
-
Industry trends
-
Hospital pharmacies
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Retail pharmacies
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
-
Market size, forecast, and annual growth, 2017-2030, (USD Million)
For more information about this report visit https://www.researchandmarkets.com/r/25v6om
Comments are closed.